Attovia Therapeutics (ATTO)

• Market cap: $1.17B
• 1 day: 5.58%
• 5 days: 23.19%
• 1 month: 16.67%
• 3 months: 16.67%
• 6 months: 16.67%
• Year to date: 16.67%
• 1 year: 16.67%
• 5 years: 16.67%
• 10 years: 16.67%
• Sector: Healthcare
• Industry: Biotechnology

About: Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.